UBS AM’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.98M | Buy |
637,861
+116,155
| +22% | +$1.09M | ﹤0.01% | 1622 |
|
|
2025
Q1 | $3.71M | Buy |
521,706
+38,521
| +8% | +$274K | ﹤0.01% | 1715 |
|
|
2024
Q4 | $5.63M | Buy |
483,185
+23,173
| +5% | +$270K | ﹤0.01% | 1549 |
|
|
2024
Q3 | $9.45M | Sell |
460,012
-52,297
| -10% | -$1.07M | ﹤0.01% | 1250 |
|
|
2024
Q2 | $11.5M | Buy |
512,309
+132,671
| +35% | +$2.97M | ﹤0.01% | 1078 |
|
|
2024
Q1 | $10.4M | Sell |
379,638
-52,374
| -12% | -$1.44M | ﹤0.01% | 976 |
|
|
2023
Q4 | $13.2M | Buy |
432,012
+24,627
| +6% | +$751K | 0.01% | 901 |
|
|
2023
Q3 | $12.9M | Sell |
407,385
-11,340
| -3% | -$359K | 0.01% | 874 |
|
|
2023
Q2 | $15.6M | Hold |
418,725
| – | – | 0.01% | 822 |
|
|
2023
Q1 | $15.6M | Buy |
418,725
+25,481
| +6% | +$950K | 0.01% | 822 |
|
|
2022
Q4 | $13.7M | Sell |
393,244
-9,831
| -2% | -$343K | 0.01% | 841 |
|
|
2022
Q3 | $22.6M | Buy |
403,075
+31,670
| +9% | +$1.77M | 0.01% | 731 |
|
|
2022
Q2 | $19.2M | Buy |
371,405
+52,001
| +16% | +$2.69M | 0.01% | 747 |
|
|
2022
Q1 | $23.2M | Buy |
319,404
+30,815
| +11% | +$2.24M | 0.01% | 808 |
|
|
2021
Q4 | $34.1M | Sell |
288,589
-727
| -0.3% | -$86K | 0.01% | 759 |
|
|
2021
Q3 | $38.8M | Buy |
289,316
+15,824
| +6% | +$2.12M | 0.02% | 697 |
|
|
2021
Q2 | $44.3M | Buy |
273,492
+42,301
| +18% | +$6.85M | 0.02% | 662 |
|
|
2021
Q1 | $18.6M | Sell |
231,191
-49,808
| -18% | -$4M | 0.01% | 881 |
|
|
2020
Q4 | $15.3M | Buy |
280,999
+215,922
| +332% | +$11.7M | 0.01% | 923 |
|
|
2020
Q3 | $1.29M | Buy |
65,077
+5,136
| +9% | +$102K | ﹤0.01% | 1740 |
|
|
2020
Q2 | $1.26M | Buy |
59,941
+11,148
| +23% | +$234K | ﹤0.01% | 1705 |
|
|
2020
Q1 | $597K | Buy |
48,793
+7,650
| +19% | +$93.6K | ﹤0.01% | 1906 |
|
|
2019
Q4 | $604K | Sell |
41,143
-1,749
| -4% | -$25.7K | ﹤0.01% | 2163 |
|
|
2019
Q3 | $573K | Buy |
42,892
+24,637
| +135% | +$329K | ﹤0.01% | 2223 |
|
|
2019
Q2 | $299K | Buy |
+18,255
| New | +$299K | ﹤0.01% | 2411 |
|
|
2018
Q4 | – | Sell |
-8,635
| Closed | -$247K | – | 2807 |
|
|
2018
Q3 | $247K | Buy |
+8,635
| New | +$247K | ﹤0.01% | 2350 |
|